Results 21 to 30 of about 49,719 (230)

Daily Dosing of Highly Active Antiretroviral Therapy [PDF]

Clinical Infectious Diseases, 2002
Complex treatment schedules for human immunodeficiency virus (HIV) disease, which can have a high pill burden and can include multiple daily doses, in addition to the adverse effects that the medications can cause, may reduce patient adherence to therapy. Reduced adherence prevents achievement of the desired goal of full suppression of HIV replication,
Keith A, Rosenbach, Robert, Allison, Jeffrey P, Nadler   +2 more
openaire   +2 more sources

Highly active antiretroviral therapy: Does it Sound toxic?

Journal of Pharmacy and Bioallied Sciences, 2011
Objective : The main objective of the current study is to monitor the auditory status in a group of adults with AIDS, receiving Highly Active Antiretroviral Therapy (HAART) (3TC -lamivudine, D4T - stavudine, and efavirenz) in a hospital outpatient clinic
Katijah Khoza-Shangase
doaj   +1 more source

Classical and alternative macrophages have impaired function during acute and chronic HIV-1 infection

Brazilian Journal of Infectious Diseases, 2017
Objectives: Three decades after HIV recognition and its association with AIDS development, many advances have emerged – especially related to prevention and treatment.
Leonardo J. Galvão-Lima, Milena S. Espíndola, Luana S. Soares, Fabiana A. Zambuzi, Maira Cacemiro, Caroline Fontanari, Valdes R. Bollela, Fabiani G. Frantz   +7 more
doaj   +1 more source

Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia. [PDF]

PLoS ONE, 2018
Human immunodeficiency virus/Acquired immunodeficiency syndrome associated morbidity and mortality has reduced significantly since the introduction of highly active antiretroviral therapy.
Genet Gebrehiwet Hailu, Dawit Gebregziabher Hagos, Amlsha Kahsay Hagos, Araya Gebreyesus Wasihun, Tsehaye Asmelash Dejene   +4 more
doaj   +1 more source

Long-term use of first-line highly active antiretroviral therapy is not associated with carotid artery stiffness in human immunodeficiency virus-positive patients

Brazilian Journal of Infectious Diseases, 2014
Objective: To evaluate whether or not highly active antiretroviral therapy is associated with carotid artery stiffness in human immunodeficiency virus-positive patients in Henan Province, China.
Haohui Zhu, Jianjun Yuan, Yisa Wang, Fan Gao, Xiao Wang, Changhua Wei, Jiyun Chen, Xiaohui Fan, Mei Zhang   +8 more
doaj   +1 more source

Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, southeast Ethiopia: A cross-sectional study

SAGE Open Medicine, 2021
Objectives: Hematological abnormalities of the major blood cell lines are frequently reported in patients with HIV-1 infection, in patients without antiretroviral therapy, and during the advanced stages of the disease.
Negesso Duguma, Girum Tesfaye Kiya, Wondimagegn Adissu Maleko, Lealem Gedefaw Bimerew   +3 more
doaj   +1 more source

Disseminated kaposi's sarcoma in an HIV-positive patient: A rare entity in an Indian patient

Indian Journal of Dermatology, 2016
AIDS-associated disseminated Kaposi sarcoma (KS) is a rare entity, especially in India due to the low prevalence of human herpes virus-8 infections in Indian population.
Biswanath Behera, Laxmisha Chandrashekar, Devinder Mohan Thappa, Pampa Ch Toi, Kolar Vishwanath Vinod   +4 more
doaj   +1 more source

Identification of serodiscordant couples, their clinical and laboratory characteristics, and vulnerabilities of HIV transmission risk in Northeastern Brazil in the era of pre-exposure prophylaxis (PrEP)

Revista Ciências em Saúde, 2020
Objectives: To evaluate the frequency of HIV serodiscordants couples and their seronegative partners who were candidates for pre-exposure prophylaxis (PrPE), and the knowledge about behavioural measures to reduce virus transmission. Methods: The research
Maíra Gomes Monteiro, Adriana Farrant Braz, Kledoaldo Lima, Heloísa Ramos Lacerda   +3 more
doaj   +1 more source

Highly Active Antiretroviral Therapy (HAART)

Eggleton JS, Nagalli S.
europepmc   +2 more sources

Viral Blip Dynamics during Highly Active Antiretroviral Therapy [PDF]

Journal of Virology, 2003
ABSTRACT Although intermittent episodes of low-level viremia are often observed in well-suppressed highly active antiretroviral therapy (HAART)-treated patients, the timing and amplitude of viral blips have never been examined in detail. We analyze here the dynamics of viral blips, i.e., plasma VL measurements of >50 copies/ml,
Michele, Di Mascio, Martin, Markowitz, Michael, Louie, Christine, Hogan, Arlene, Hurley, Chris, Chung, David D, Ho, Alan S, Perelson   +7 more
openaire   +2 more sources